Aonong Biotech announced that the company and four relevant parties, Wu Yulin, Peng Jiang, Su Mingcheng, and Yangzhou, received the Fujian Securities Regulatory Bureau's “Advance Notice of Administrative Penalties”. After investigation, the company failed to disclose major lawsuits and arbitrations in accordance with regulations, and illegal disclosures of related transactions. The Fujian Securities Regulatory Bureau plans to order the company to make corrections, give a warning, and impose a fine of 2.5 million yuan, give separate warnings to the 4 persons responsible, and impose fines ranging from 200,000 yuan to 1.4 million yuan. The acts involved in this case did not touch on other risk warnings or major illegal forced delisting situations. The final penalty results are subject to the formal decision.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.